Pharmala Biotech Holdings (MDMA) Cash on Hand

MDMA Cash on Hand in 2022: $135.80K

According to Pharmala Biotech Holdings latest financial reports the cash on hand of MDMA is $135.80K, an decrease of -77.11% to 2022. At the end of 2022 company had $593.33K cash on hand. This amount reflects the liquid assets available to the company, which are crucial for its operational flexibility, investment opportunities, and overall financial security.

MDMA Cash on Hand History from 2021 to 2023

MDMA Cash on Hand by year

View the Top Cash on Hand Companies